Sort
30,917 grants matching “tumor microenvironment”
Immune Exclusion in Cancer Immunotherapy
$604,941Riyue Bao · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DE
Immune Exclusion in Cancer Immunotherapy
$604,941Riyue Bao · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DE
Glial Origin and Signaling in Medulloblastoma
$604,852Qing R Lu · Cincinnati Childrens Hosp Med Ctr · R01 · FY2025 · NS
Effects of Arginine Depletion Combined with Platinum-Taxane Chemotherapy in Aggressive Variant Prostate Cancers (AVPC)
$604,748Ana Aparicio · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Deconvoluting CAR T cell heterogeneity to engineer durable antitumor protection
$604,627Yina Hsing Huang · Dartmouth College · R01 · FY2025 · CA
Mitochondrial Metabolism and Cancer
$604,507Navdeep S. Chandel · Northwestern University At Chicago · R01 · FY2025 · CA
Immunobiology and immunotherapy of pancreatic cancer
$604,414Robert H Vonderheide · University Of Pennsylvania · R01 · FY2014 · CA
Regulators of Cancer Immunotherapy Response
$604,374Myles A Brown · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Toward Translation of an Immunotherapeutic Nanomedicine for Neuroblastoma
$604,335John Tanner Wilson · Vanderbilt University · R01 · FY2022 · CA
Macrophage development and specification in mice.
$604,090Frederic Geissmann · Sloan-Kettering Inst Can Research · R01 · FY2021 · AI
Macrophage development and specification in mice.
$604,090Frederic Geissmann · Sloan-Kettering Inst Can Research · R01 · FY2020 · AI
Cancer Immunotherapy Clinical Trials
$603,896Christopher Heery · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Development of novel protein-based therapeutics for lung cancer
$603,877Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2018 · CA
Shaping the Microenvironment by DPEP1 Facilitates Adenoma Progression
$603,822Robert J Coffey · Vanderbilt University Medical Center · U54 · FY2024 · CA
Understanding and targeting the DNA replication stress in cancer cells
$603,796Lee Zou · Duke University · R35 · FY2024 · CA
Neuronal Regulation of Low-Grade Gliomagenesis
$603,598Michelle Monje-Deisseroth · Stanford University · R01 · FY2024 · CA
Re-wiring PDAC Tumor Immunity Through Dendritic Cells
$603,590David G Denardo · Washington University · R01 · FY2022 · CA
Linking the microbiome and immune-checkpoint in melanoma by RNF5
$603,580Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · CA
Linking the microbiome and immune-checkpoint in melanoma by RNF5
$603,580Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · CA
Linking the microbiome and immune-checkpoint in melanoma by RNF5
$603,580Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2021 · CA
A âSTICKâ theranostic nanoplatform for image-guided drug delivery to brain malignancies
$603,509Yuanpei Li · University Of California At Davis · R01 · FY2024 · EB
Mechanoimmunological interactions between TCR-T cells and tumor fibrotic microenvironment
$603,501Ruogang Zhao · State University Of New York At Buffalo · R01 · FY2025 · CA
The roles of EBV-specific T cells in response to checkpoint blockade immunotherapy of EBV-driven nasopharyngeal carcinoma
$603,444Evan Newell · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
The roles of EBV-specific T cells in response to checkpoint blockade immunotherapy of EBV-driven nasopharyngeal carcinoma
$603,444Evan Newell · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
Combinatorial Immunotherapy using a Multivalent Drug Conjugate for GBM Treatment
$603,422Waldemar Debinski · Wake Forest University Health Sciences · R01 · FY2025 · CA